Lantern Pharma (LTRN) Other Operating Expenses (2019 - 2023)
Lantern Pharma's (LTRN) quarterly Other Operating Expenses came in at -$42000.0 in Q1 2023, down 7.69% YoY from -$45500.0 in Q1 2022, and down 16.67% on a QoQ basis from -$36000.0 in Q4 2022.
Lantern Pharma (LTRN) Other Operating Expenses (2019 - 2023) Analysis & Trends
Lantern Pharma (LTRN) has 5 years of Other Operating Expenses data on file, last reported at -$42000.0 in Q1 2023.
- Quarterly Other Operating Expenses fell 7.69% year-over-year to -$42000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was -$42000.0 (up 70.83% YoY) and the FY2022 annual result came in at -$144000.0, down 37.14% from the prior year.
- Other Operating Expenses eased to -$42000.0 in Q1 2023, from -$36000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $228401.0 in Q3 2019 to a low of -$42000.0 in Q1 2023.
- A 5-year average of $7133.4 and a median of -$28500.0 in 2021 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2021 — Other Operating Expenses sank 3700.0% — and 2022, when it gained 21.05%.
- Tracing LTRN's Other Operating Expenses over 5 years: stood at $177467.0 in 2019, then slumped by 101.13% to -$2000.0 in 2020, then tumbled by 1800.0% to -$38000.0 in 2021, then gained by 5.26% to -$36000.0 in 2022, then fell by 16.67% to -$42000.0 in 2023.
- The last three Other Operating Expenses figures came in at -$42000.0 (Q1 2023), -$36000.0 (Q4 2022), and -$30000.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lantern Pharma | 26.05 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -42,000.00 |
| Dec 31, 2022 | -36,000.00 |
| Sep 30, 2022 | -30,000.00 |
| Jun 30, 2022 | -39,000.00 |
| Mar 31, 2022 | -39,000.00 |
| Dec 31, 2021 | -38,000.00 |
| Sep 30, 2021 | -38,000.00 |
| Jun 30, 2021 | -27,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -2,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Jun 30, 2020 | -12,000.00 |
| Dec 31, 2019 | 177,467.00 |
| Sep 30, 2019 | 228,401.00 |